MOLLY BONDS: Open Payments
NPI 1790381143 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 23 payments from 9 companies in 2025. Trend: 2023 $249 · 2024 $538 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $187 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Calliditas Therapeutics US Inc. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
Products named: Fabhalta, JARDIANCE, JYNARQUE, TARPEYO, FARXIGA, PURIFIED CORTROPHIN GEL, Kerendia, TERLIVAZ.
Industry payments across AL — which companies pay providers there.
